Novo’s Wegovy pill linked to 6.2% average weight loss over three months

Real-world data show patients who stayed on Novo Nordisk’s daily Wegovy pill lost an average of 6.2% of body weight over three months. The data are due to be presented at the ObesityWeek conference in Washington.